Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TDM-105795 in male androgenetic alopecia
NCT05802173Phase 2Completed
- Sponsor
- TechnoDerma Medicines Inc.
- Start
- Mar 2023
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of TDM-105795 in androgenetic alopecia (AGA), sponsored by TechnoDerma Medicines Inc.. Started Mar 2023; status: completed.
02
Drugs
TDM-105795
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on NCT05802173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05802173.